|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.50 INR | -2.00% |
|
+3.55% | +70.40% |
| May. 21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| May. 20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.56B 67.94M 59.54M 55.32M 50.82M 95.73M 97.22M 658M 257M 3.21B 255M 250M 11.08B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.42B 76.88M 67.38M 62.6M 57.5M 108M 110M 745M 291M 3.63B 289M 282M 12.54B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.79% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | -2.00% | ||
| 1 week | +3.55% | ||
| Current month | -1.45% | ||
| 1 month | +2.55% | ||
| 3 months | +46.16% | ||
| 6 months | +72.92% | ||
| Current year | +70.40% |
| 1 week | 122.5 | 125.5 | |
| 1 month | 111.5 | 133.95 | |
| Current year | 59.72 | 133.95 | |
| 1 year | 59.72 | 133.95 | |
| 3 years | 59.72 | 151.75 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 2001-12-31 |
| Director of Finance/CFO | - | 2019-03-31 | |
| Director of Finance/CFO | - | 1990-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 1989-12-31 |
| Director/Board Member | - | 1990-12-31 | |
Prakash Sapkal
BRD | Director/Board Member | - | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.00% | +3.55% | +2.47% | +2.08% | 68.11M | ||
| -0.96% | +0.02% | +14.81% | +77.10% | 48.88B | ||
| -0.99% | -0.27% | +66.69% | +108.95% | 35.72B | ||
| -1.21% | -1.60% | -3.99% | +34.91% | 12.02B | ||
| -1.47% | -0.64% | +16.11% | +83.68% | 11.84B | ||
| -0.37% | +0.94% | +34.42% | +136.73% | 8.95B | ||
| +0.33% | -1.13% | +50.36% | -5.96% | 6.91B | ||
| -0.34% | -2.41% | +14.20% | +33.03% | 6.78B | ||
| -1.88% | -4.56% | +0.69% | +192.09% | 6.57B | ||
| -2.47% | -5.28% | -33.67% | +6.76% | 5.81B | ||
| Average | -1.14% | -1.64% | +16.21% | +66.94% | 14.35B | |
| Weighted average by Cap. | -1.01% | -0.36% | +26.55% | +82.05% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.27M 34.41M 31.98M 29.37M 55.33M 56.19M 381M 149M 1.85B 147M 144M 6.41B | 3.74B 38.78M 33.98M 31.58M 29M 54.64M 55.49M 376M 147M 1.83B 146M 142M 6.33B |
| Net income | 122M 1.26M 1.1M 1.03M 942K 1.78M 1.8M 12.21M 4.78M 59.45M 4.73M 4.63M 206M | 58.38M 605K 530K 492K 452K 852K 865K 5.86M 2.29M 28.53M 2.27M 2.22M 98.64M |
| Net Debt | 1.16B 11.99M 10.51M 9.76M 8.97M 16.89M 17.16M 116M 45.44M 566M 45.01M 44.03M 1.96B | 863M 8.94M 7.83M 7.28M 6.69M 12.59M 12.79M 86.63M 33.88M 422M 33.55M 32.83M 1.46B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-21 | ₹122.50 | -2.00% | 400 |
| 26-07-20 | ₹125.00 | -0.36% | 2,296 |
| 26-07-17 | ₹125.45 | +1.95% | 8,530 |
| 26-07-16 | ₹123.05 | +1.99% | 3,069 |
| 26-07-15 | ₹120.65 | +1.99% | 5,681 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















